SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001352189-19-000003
Filing Date
2019-05-29
Accepted
2019-05-29 13:31:27
Documents
1
Effectiveness Date
2019-05-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11081
  Complete submission text file 0001352189-19-000003.txt   12261
Mailing Address 20 TW ALEXANDER DRIVE SUITE 110 DURHAM NC 27709
Business Address 20 TW ALEXANDER DRIVE SUITE 110 DURHAM NC 27709 (919) 561-6210
Asklepios BioPharmaceutical, Inc. (Filer) CIK: 0001352189 (see all company filings)

IRS No.: 200267834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-340600 | Film No.: 19860880